Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer: A meta-analysis.

Huang, Lei; Huang, Hao; Zhou, Xiao-Ping; Liu, Jin-Feng; Li, Chun-Rong; Fang, Min; Wu, Jun-Rong

Huang, Lei; Huang, Hao; Zhou, Xiao-Ping; Liu, Jin-Feng; Li, Chun-Rong; Fang, Min; Wu, Jun-Rong.

Affiliation

Huang L; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.
Huang H; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.
Zhou XP; Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Liu JF; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.
Li CR; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.
Fang M; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.
Wu JR; Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University.

Medicine (Baltimore) ; 98(43): e17705, 2019 Oct.

Article in En | MEDLINE | ID: mdl-31651902

Subject(s)

Acrylamides/therapeutic use; Aniline Compounds/therapeutic use; Antineoplastic Agents/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/genetics; Lung Neoplasms/drug therapy; Lung Neoplasms/genetics; Protein Kinase Inhibitors/therapeutic use; ErbB Receptors/genetics; Humans; Mutation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Aniline Compounds / Lung Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google